Coefficients in the CAVI Equation and the Comparison Between CAVI With and Without the Coefficients Using Clinical Data

J Atheroscler Thromb. 2019 May 1;26(5):465-475. doi: 10.5551/jat.44834. Epub 2018 Dec 4.

Abstract

Aim: The Cardio-Ankle Vascular Index (CAVI) is a stiffness index of the arterial tree from the origin of the aorta to the ankle, independent of blood pressure at the time of measurement. The CAVI equation includes the coefficients "a" and "b" to adjust it to the value of Hasegawa's pulse wave velocity, which is compensated for at 80 mmHg of diastolic pressure. To verify this adjustment with the coefficients, the clinical significance of CAVI and CAVI without the coefficients (haβ) were compared in both an epidemiological study and an acute clinical study.

Methods: In the epidemiological study, the significances of CAVI and haβ among people with or without coronary risks such as hypertension, dyslipidemia, hyperglycemia, and abnormal electrocardiography change, were compared. In the acute clinical study, nitroglycerin was administered to subjects in a control group and to coronary artery disease patients, observing CAVI and haβ values over a 20-min period.

Results: There was no discrepancy in terms of statistically significant differences between CAVI and haβ among subjects with or without risk factors. Furthermore, there was also no discrepancy in terms of statistically significant differences between CAVI and haβ during the changes of those values following nitroglycerin administration over a 20-min period.

Conclusion: In both the epidemiologic and clinical studies, there was no discrepancy in terms of significant differences between CAVI and haβ. These results suggest that both are valid as indices of stiffness of the arterial tree from the origin of the aorta to the ankle.

Keywords: CAVI; Hasegawa’s pulse wave velocity; Stiffness Parameter β; haβ.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood*
  • C-Reactive Protein / analysis*
  • Case-Control Studies
  • Coronary Angiography
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / etiology*
  • Female
  • Follow-Up Studies
  • Homocysteine / blood*
  • Humans
  • Lipoprotein(a) / blood*
  • Male
  • Middle Aged
  • Peripheral Arterial Disease / blood
  • Peripheral Arterial Disease / complications*
  • Prognosis
  • Prospective Studies
  • Risk Factors
  • Survival Rate

Substances

  • Biomarkers
  • Lipoprotein(a)
  • Homocysteine
  • C-Reactive Protein